Quadrature Capital Ltd Sells 17,595 Shares of The Allstate Co. (NYSE:ALL)

Quadrature Capital Ltd trimmed its position in The Allstate Co. (NYSE:ALL - Free Report) by 27.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 46,498 shares of the insurance provider's stock after selling 17,595 shares during the period. Quadrature Capital Ltd's holdings in Allstate were worth $8,815,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the stock. FSA Wealth Management LLC bought a new position in shares of Allstate in the third quarter worth approximately $26,000. Northwest Investment Counselors LLC acquired a new stake in Allstate in the third quarter valued at approximately $28,000. Catalyst Capital Advisors LLC purchased a new position in Allstate during the third quarter worth approximately $29,000. Family Firm Inc. acquired a new stake in Allstate in the 2nd quarter valued at approximately $38,000. Finally, MCF Advisors LLC increased its position in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock valued at $53,000 after purchasing an additional 84 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the business's stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. The trade was a 57.06 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.80% of the stock is owned by company insiders.

Allstate Stock Down 0.0 %

Shares of Allstate stock traded down $0.04 on Thursday, hitting $204.91. 632,484 shares of the company's stock traded hands, compared to its average volume of 1,547,214. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a 52-week low of $134.17 and a 52-week high of $209.88. The firm's 50-day moving average is $193.78 and its 200 day moving average is $179.86. The stock has a market cap of $54.26 billion, a P/E ratio of 13.28, a PEG ratio of 1.79 and a beta of 0.50.

Allstate (NYSE:ALL - Get Free Report) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm's quarterly revenue was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.81 EPS. Equities analysts anticipate that The Allstate Co. will post 16.26 earnings per share for the current year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date is Friday, November 29th. Allstate's dividend payout ratio (DPR) is presently 23.83%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on ALL shares. Roth Mkm reaffirmed a "buy" rating and set a $200.00 price target on shares of Allstate in a research note on Wednesday, August 14th. JPMorgan Chase & Co. upped their price target on shares of Allstate from $205.00 to $207.00 and gave the company an "overweight" rating in a report on Thursday, October 10th. Piper Sandler raised their price target on Allstate from $206.00 to $244.00 and gave the company an "overweight" rating in a report on Tuesday, November 26th. Barclays raised their price objective on Allstate from $175.00 to $187.00 and gave the stock an "underweight" rating in a research note on Thursday, October 31st. Finally, Bank of America lifted their price objective on Allstate from $216.00 to $233.00 and gave the company a "buy" rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Allstate has a consensus rating of "Moderate Buy" and an average price target of $217.19.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.